Product image of Hydromorphone Kalceks (Hydromorphone Hydrochloride) supplied by GNH India

Hydromorphone Kalceks

Active Ingredient:
Hydromorphone Hydrochloride
Origin:
EU

Hydromorphone Kalceks (Hydromorphone Hydrochloride)

Hydromorphone Hydrochloride, the active ingredient in Hydromorphone Kalceks, is an opioid analgesic presented as a sterile injectable solution for intravenous and subcutaneous use. It treats moderate to severe acute pain, post‑operative pain, and cancer‑related pain in adult patients.
GNH India supplies Hydromorphone Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hydromorphone Kalceks is an opioid analgesic that acts on the μ‑opioid receptor pathway to relieve pain.

  • Moderate to severe acute pain: provides rapid analgesia for patients experiencing intense short‑term pain.
  • Post‑operative pain: helps control pain following surgical procedures.
  • Cancer‑related pain: offers relief for persistent pain associated with malignant disease.

How It Works

  • Hydromorphone Hydrochloride binds selectively to μ‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and neurotransmitter release. This results in decreased perception of pain and increased analgesic and sedative effects.

Side Effects

Hydromorphone Kalceks may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Constipation: reduced bowel motility.
  • Drowsiness: increased sleepiness.
  • Dry mouth: reduced salivation.
  • Itching: mild pruritus.
  • Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects

  • Respiratory depression: markedly slowed breathing.
  • Severe hypotension: dangerous drop in blood pressure.
  • Seizures: rare convulsive episodes.
  • Anaphylaxis: life‑threatening allergic reaction.
  • Dependence or addiction: potential for misuse with prolonged use.

Precautions & Warnings

Use Hydromorphone Kalceks with careful clinical monitoring.

  • Respiratory assessment: evaluate breathing function before and during therapy.
  • Sedation monitoring: watch for excessive drowsiness or loss of consciousness.
  • Dose adjustment: reduce dose in patients with renal or hepatic impairment.
  • Concomitant CNS depressants: avoid or limit use with other sedatives.
  • Elderly patients: start with the lowest effective dose and monitor closely.
  • Store at controlled room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Hydromorphone Kalceks can interact with several drug classes.

Major Interactions (Avoid)

  • MAO inhibitors: risk of severe hypertension or serotonin syndrome.
  • Other opioid analgesics: additive respiratory depression.
  • CNS depressants (benzodiazepines, barbiturates): increased sedation and respiratory risk.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may raise hydromorphone plasma levels.
  • Antihistamines: can enhance sedation and dizziness.

Frequently Asked Questions

Hydromorphone Kalceks is prescribed to manage moderate to severe acute pain, post‑operative pain, and cancer‑related pain. It provides rapid analgesia by acting on central μ‑opioid receptors, making it suitable for patients who need strong opioid therapy under medical supervision.

Hydromorphone hydrochloride binds to μ‑opioid receptors in the brain and spinal cord, activating inhibitory pathways that lower neuronal excitability and reduce the transmission of pain signals. This mechanism produces both analgesic and sedative effects.

The specific dose of Hydromorphone Kalceks is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, renal and hepatic function, and overall clinical condition. Dosing is individualized and should follow local prescribing guidelines.

The safety of hydromorphone in pregnancy and lactation is not well established. It is classified as a Category unknown drug, and use is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Consultation with a specialist is recommended.

To request Hydromorphone Kalceks, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Hydromorphone is a more potent opioid than morphine on a milligram‑for‑milligram basis, offering stronger analgesia with a shorter onset of action. Both act on μ‑opioid receptors, but hydromorphone may produce fewer histamine‑related side effects, while morphine is often used when a longer duration of effect is desired.

Hydromorphone Kalceks should be stored at controlled room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability and potency.

Hydromorphone Kalceks is supplied as a sterile injectable solution and is administered intravenously or subcutaneously by a qualified healthcare professional. The route, rate, and volume are determined by the prescriber according to the patient’s clinical needs.

The most serious risks include respiratory depression, severe hypotension, profound sedation, and the potential for dependence or addiction. Prompt recognition of these events and immediate medical intervention are essential to prevent life‑threatening complications.

Hydromorphone Kalceks is contraindicated in patients with known hypersensitivity to hydromorphone or any component of the formulation, those who have taken MAO inhibitors within the past 14 days, and individuals with severe respiratory insufficiency or uncontrolled asthma.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hydromorphone Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT